Have you started working on past exams for Kyoto University of Advanced Science Junior High School, but are unsure about ...

ISASOCUT: Subcutaneous Isatuximab With On-Body Injector in Newly Diagnosed Multiple Myeloma / cancer, Headlines, Hematology, ...

Swiss startup Atlas Bio raises $12.5M to build in silico clinical trials and tackle the 70% Phase II failure rate. What is ...

Sacituzumab tirumotecan improved survival vs chemotherapy in patients with advanced or recurrent endometrial cancer after platinum and immunotherapy.

A techno-economic analysis of recombinant lipase production in Pichia pastoris finds that secreted protein titre and ...

Babka market to grow from USD 772.4 Mn in 2026 to USD 2,213.0 Mn by 2036 at an 11.1% CAGR. Get segment, region & competitor ...

As the middle school entrance exam approaches, many families begin full-scale practice with past papers from their target ...

Results support continued evaluation of the investigational RYBREVANT FASPRO regimen in the ongoing first-line Phase 3 study Data highlight the role of dual-targeting EGFR and MET, key drivers of ...

Interpreted] Thank you very much for joining us today for Takeda's 2026 Q2 earnings announcement despite your busy schedules.

Welcome to the Merck and Company, Inc. By New Jersey USA Third Quarter Sales and Earnings Conference Call. At this time, all ...